Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733125 | PMC |
http://dx.doi.org/10.1093/annonc/mdn653 | DOI Listing |
Curr Probl Diagn Radiol
December 2023
Mallinckrodt Institute of Radiology, St. Louis, MO.
J Oral Implantol
August 2022
Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan.
The effect of bevacizumab-related osteonecrosis of the jaw on previously osseointegrated dental implants has not been adequately studied. Here, we report a case of osteonecrosis of the jaw detected around dental implants placed before bevacizumab therapy. A 66-year-old woman undergoing bevacizumab therapy for metastatic triple-negative breast cancer developed malocclusion after buccal gingival swelling and pain in the #18, #19, and #20 tooth region.
View Article and Find Full Text PDFOxf Med Case Reports
May 2019
Oncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Osteonecrosis is a multifactorial process that can affect different skeletal structures of the body. Osteonecrosis of the jaw associated with bevacizumab, steroids and bisphosphonates, alone or in combination, is a well-documented phenomenon. There are few cases of involvement of the appendicular skeleton.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!